drug_type
RELEVANT_DRUG
intervention_type
Biologic
drug_description
Anti-CD38 monoclonal antibody mediating ADCC, CDC, and ADCP and depleting immunosuppressive CD38+ cells; administered subcutaneously.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_mesh_term
Daratumumab
drug_category
CYTOTOXIC ANTIBODY
drug_class
Inhibitor
drug_delivery_route
Subcutaneous
drug_mechanism_of_action
Anti-CD38 monoclonal antibody that binds CD38 on myeloma and immunosuppressive cells and induces cell killing via Fc-mediated ADCC, CDC, and ADCP, depleting CD38+ cells and enhancing antitumor immunity (administered subcutaneously).
drug_name
Daratumab
nct_id_drug_ref
NCT05572229